Eid2 antibody - C-terminal region
Rabbit Polyclonal Antibody
- 产品详情
- 实验流程
Application ![]()
| WB |
---|---|
Primary Accession | Q6X7S9 |
Other Accession | NM_198425, NP_940817 |
Reactivity | Human, Mouse, Rat, Dog, Guinea Pig, Bovine |
Predicted | Human, Mouse, Rat, Guinea Pig, Bovine |
Host | Rabbit |
Clonality | Polyclonal |
Calculated MW | 25304 Da |
Gene ID | 386655 |
---|---|
Alias Symbol | Cri2, EID-2 |
Other Names | EP300-interacting inhibitor of differentiation 2, EID-2, CREBBP/EP300 inhibitor 2, EID-1-like inhibitor of differentiation 2, Eid2 {ECO:0000312|EMBL:AAH94513.1, ECO:0000312|MGI:MGI:2681174} |
Format | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reconstitution & Storage | Add 50 ul of distilled water. Final anti-Eid2 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles. |
Precautions | Eid2 antibody - C-terminal region is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | Eid2 {ECO:0000312|EMBL:AAH94513.1, ECO:0000312|MGI:MGI:2681174} |
---|---|
Function | Interacts with EP300 and acts as a repressor of MYOD- dependent transcription and muscle differentiation. Inhibits EP300 histone acetyltransferase activity. Acts as a repressor of TGFB/SMAD transcriptional responses. May act as a repressor of the TGFB/SMAD3- dependent signaling by selectively blocking formation of TGFB-induced SMAD3-SMAD4 complex (By similarity). |
Cellular Location | Nucleus {ECO:0000250|UniProtKB:Q8N6I1}. |
Tissue Location | Expressed in heart, brain, kidney and pancreas. Not detected in placenta. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Ji A.,et al.Gene 318:35-43(2003).

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.